Back

The incidence and risk factors of newly-diagnosed cancer after diagnosis of venous thromboembolism: from the COMMAND VTE Registry-2

26 August 2023 (15:15 - 15:50)
Organised by: Logo
Congress Presentation Part of: Mechanisms of acute pulmonary embolism: lifting the curtain Venous Thromboembolism ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yugo Yamashita

Kyoto University Graduate School of Medicine, Kyoto (Japan)

6 More presentations in this session

Presentation thumbnail
Right ventricular global work efficiency provides the highest prediction for improvements in right ventricle to left ventricle diameter ratio with acute pulmonary embolism treatments
Doctor B. Keskin B (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism
Mrs A. Eggers (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and other thrombophilia genes in patients with acute pulmonary embolism
Doctor I. Civirjic (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
Impact of pulmonary embolism on COVID-19 pneumonia hospitalizations: analysis of the national inpatient sample 2020
Doctor M. Kodali (Milwaukee, US)
Abstract Slides Video
Presentation thumbnail
Long-term risk of pulmonary embolism and deep venous thrombosis after COVID-19: a population-based cohort study
Associate Professor H. Sjoland (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of acute pulmonary embolism: lifting the curtain

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Age- and sex- specific rate of venous thromboembolism in cancer survivors: a nationwide cohort study
thumbnail
Congress Presentation
Clinical features and long-term outcomes of cancer-associated venous thromboembolism: transition from the warfarin era to the direct oral anticoagulant era
thumbnail
Congress Presentation
Safety and effectiveness of initial high-dose anticoagulation therapy for cancer-associated venous thromboembolism in the real world: insight from the COMMAND VTE Registry-2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources